Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
NVCR holding history
NovoCure Ltd in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVCR overviewAll 13F holders of NVCRFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −7,406−100.0% | Sold out | Holders |
| Q2 2023 | 7,406 | $307.3K | <0.1% | +906+13.9% | Added | Holders |
| Q1 2023 | 6,500 | $390.9K | <0.1% | −300−4.4% | Reduced | Holders |
| Q4 2022 | 6,800 | $498.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 6,800 | $517.0K | <0.1% | −100−1.4% | Reduced | Holders |
| Q2 2022 | 6,900 | $480.0K | <0.1% | −30.0% | Reduced | Holders |
| Q1 2022 | 6,903 | $572.0K | <0.1% | +6,903 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −1,775−100.0% | Sold out | Holders |
| Q2 2021 | 1,775 | $394.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 1,775 | $235.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.